No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy

Journal of Neurology

Volumn 255, Issue 12, 2008, Pages 1900-1903

  Valko, P O ^a   Khatami, R ^a   Baumann, C R ^a   Bassetti, C L ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cataplexy; Excessive daytime sleepiness; Intravenous immunoglobulins; Narcolepsy

Indexed keywords

DEXAMPHETAMINE; FLUOXETINE; GLUCOSE; IMMUNOGLOBULIN; MAZINDOL; METHYLPHENIDATE; METHYLPREDNISOLONE; MODAFINIL; OLIGOCLONAL BAND; OREXIN; PROTEIN; VENLAFAXINE;

ADULT; ARTICLE; CASE REPORT; CATAPLEXY; COMMON VARIABLE IMMUNODEFICIENCY; DAYTIME SOMNOLENCE; DISABILITY; DREAM; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EMOTION; EPSWORTH SLEEPINESS SCALE; FEMALE; HUMAN; HYPNAGOGIC HALLUCINATION; MALE; MENTAL STRESS; NARCOLEPSY; NIGHT SLEEP; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASOMNIA; PLEOCYTOSIS; PRIORITY JOURNAL; RATING SCALE; SLEEP DISORDER; WEIGHT GAIN; WHITE MATTER;

ADULT; CATAPLEXY; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; NARCOLEPSY; TIME FACTORS;

EID: 67349139579     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-008-0996-2     Document Type: Article

References (11)

1. Bassetti 2005 Neurology 65 1152
2. Crocker 2005 Neurology 65 1184
3. Dauvilliers 2004 Ann Neurol 56 905
4. Dauvilliers 2006 Ann Neurol 60 153
5. Fronczek 2007 J Neurol 254 1607
6. Hecht 2003 Sleep 26 809
7. Hublin 1994 Sleep 17 S7
8. Lecendreux 2003 J Sleep Res 12 347
9. Salzer 2006 Semin Immunol 18 337
10. Sturzenegger 2004 J Sleep Res 13 395
11. The U.S. Xyrem Multicenter Study Group (2002) A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 25:42-49